May 15, 2025
MediPharm Labs Raises Concerns About Poorly Qualified Dissident Nominees
May 14, 2025
MediPharm Labs Announces Strong Q1 2025 Results
May 09, 2025
MediPharm Labs Sets Date to Report First Quarter 2025 Financial Results
Mar 31, 2025
MediPharm Labs Reports Full Year & Fourth Quarter 2024 Results
Jan 08, 2025
MediPharm Labs Enters Landmark Commercial Agreement with Laboratório Teuto in Brazil
Dec 17, 2024
MediPharm Labs to Sell its Napanee Facility to Kensana Health for $5.5M
Nov 14, 2024
MediPharm Labs Reports Third Quarter Results
Nov 11, 2024
MediPharm Labs Sets Date to Report Third Quarter 2024 Financial Results
Oct 17, 2024
MediPharm Labs Announces Departure of President and Co-Founder Keith Strachan
Sep 17, 2024
MediPharm Labs Announces $2.1M Debt Repayment
Aug 14, 2024
MediPharm Labs Reports Second Quarter Results Closing in on Positive Adjusted EBITDA(1) as Gross Profit Continues to Improve
Aug 13, 2024
/R E P E A T -- MediPharm Labs Sets Date to Report Second Quarter 2024 Financial Results/
Aug 08, 2024
MediPharm Labs Sets Date to Report Second Quarter 2024 Financial Results
Jun 20, 2024
MediPharm Labs Acquires Advanced Medical Cannabis Delivery Method Technology from Remidose Aerosols
May 15, 2024
MediPharm Labs Reports First Quarter Results
May 08, 2024
MediPharm Labs Sets Date to Report First Quarter 2024 Financial Results
Mar 27, 2024
MediPharm Labs Reports Fourth Quarter and Full Year Results
Mar 27, 2024
MediPharm Labs Reports Fourth Quarter and Full Year Results
Mar 27, 2024
MediPharm Labs Provides Conference Call Recording Details
Mar 25, 2024
MediPharm Labs Provides Update on German Cannabis Legalization